USA - engelsk - NLM (National Library of Medicine)

vistapharm, inc. - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - ibuprofen 100 mg in 5 ml - carefully consider the potential benefits and risks of ibuprofen oral suspension and other treatment options before deciding to use ibuprofen. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). in pediatric patients, ibuprofen oral suspension is indicated: - for reduction of fever in patients aged 6 months up to 2 years of age. - for relief of mild to moderate pain in patients aged 6 months up to 2 years of age. - for relief of signs and symptoms of juvenile arthritis. in adults, ibuprofen oral suspension is indicated: - for treatment of primary dysmenorrhea. - for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. since there have been no controlled trials to demonstrate whether there is any beneficial effect or harmful interaction with the use of ibuprofen in conjunction with aspirin, the combination cannot be recommended (see precautions - drug interactions ). ibuprofen is contraindicated in patients with kno

USA - engelsk - NLM (National Library of Medicine)

a-s medication solutions - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - ibuprofen 600 mg - carefully consider the potential benefits and risks of ibuprofen tablets and other treatment options before deciding to use ibuprofen tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see warnings ]. ibuprofen tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. ibuprofen tablets are indicated for relief of mild to moderate pain. ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea. controlled clinical trials to establish the safety and effectiveness of ibuprofen tablets, usp in children have not been conducted. ibuprofen tablets are contraindicated in patients with known hypersensitivity to ibuprofen. ibuprofen tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients [see warnings,  anap

Canada - engelsk - Health Canada

pharmascience inc - ibuprofen - tablet - 400mg - ibuprofen 400mg - other nonsteroidal antiimflammatory agents

Canada - engelsk - Health Canada

pharmascience inc - ibuprofen - tablet - 200mg - ibuprofen 200mg - other nonsteroidal antiimflammatory agents

Canada - engelsk - Health Canada

pharmascience inc - ibuprofen - tablet - 200mg - ibuprofen 200mg - other nonsteroidal antiimflammatory agents

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - ibuprofen -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - ibuprofen -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

reckitt benckiser pty ltd - ibuprofen -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

glaxosmithkline consumer healthcare australia pty ltd - ibuprofen -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

glaxosmithkline consumer healthcare australia pty ltd - ibuprofen -